Clinical Trial Update: A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality [Phase 3]

View source ↗

Summary

A Phase 3 double-blind trial tests buprenorphine for acute suicidality in depressed patients; the current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Suicidal Ideation

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Abarbanel Mental Health Center | Conditions: Depression, Suicidal Ideation | Phase 3 | Status: UNKNOWN